From an examination of the contents of the draft intellectual property section of the pending Pacific Rim trade pact by Carolina Rossini, at the Internet project director for the New America Foundation’s Open Technology Institute Governance and Human Rights Latin America Resource Center, and Burcu Kilic, legal counsel for Public Citizen’s Global Access to Medicines Program, writing in Al Jazeera America:
Since Wikileaks made the intellectual property (IP) chapter public, multiple organizations have provided extensive and detailed critiques. According to these analyses, the text demonstrates U.S. preference for increasing protections on existing copyrights and patents over balanced policies that promote global innovation, creativity and political freedom. The disclosures especially suggest the inordinate influence of the motion picture and pharmaceutical industries. In the first brief interview commenting on the leak, the U.S. Trade Representative Michael Froman defended the proposal saying it is within the bounds of U.S. law. He happened to make this comment while touring Paramount Pictures studios in Los Angeles.
Further analysis of the IP chapter shows that it violates international consensus on several important issues. First, the U.S. is pushing provisions that conflict with the World Intellectual Property Organization’s Development Agenda, which requires that development concerns be a formal part of global IP policy. Second, the chapter also takes a controversial approach to the World Trade Organization’s (WTO) Doha Declaration on the Trade Related Aspects of Intellectual Property Rights (TRIPS) and Public Health. TRIPS sets the standards for intellectual property protection in the world today, which are binding on all members of WTO. The Doha Declaration affirms that TRIPS signatories should interpret and implement TRIPS in a manner supportive of their own rights to protect public health and, in particular, to promote access to medicines for all. Although the IP chapter makes explicit reference to the Doha Declaration, the IP chapter is designed to narrow its scope, thereby limiting access to medicines and restricting what governments can do to protect public health.
Third, U.S. proposals also contradict the current policy discussions on access to medicines and on research & development at the World Health Organization and the UN Convention on Biological Diversity. Fourth, the TPP chapter also jeopardizes the flexibilities guaranteed under fair use doctrine by pushing for strict enforcement of copyrights online.